Western blot assay confirmed that the phosphorylation levels of EGFR and ErbB2 were down-regulated when knocking down CD151 and up-regulated when overexpressing CD151 in NSCLC cells. The gene discussed is ERBB2; the disease is non-small cell lung carcinoma.